These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8430518)

  • 1. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.
    De Clercq E
    Adv Virus Res; 1993; 42():1-55. PubMed ID: 8430518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective virus inhibitors.
    De Clercq E
    Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.
    De Clercq E; Murase J; Marquez VE
    Biochem Pharmacol; 1991 Jun; 41(12):1821-9. PubMed ID: 1710119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.
    De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1395-415. PubMed ID: 16438025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.
    De Clercq E; Andrei G; Snoeck R; De Bolle L; Naesens L; Degrève B; Balzarini J; Zhang Y; Schols D; Leyssen P; Ying C; Neyts J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):271-85. PubMed ID: 11563039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
    De Clercq E
    Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
    Markland W; McQuaid TJ; Jain J; Kwong AD
    Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights in the development of new antiviral agents.
    De Clercq E
    Mini Rev Med Chem; 2002 Apr; 2(2):163-75. PubMed ID: 12370077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV inhibitors targeted at the reverse transcriptase.
    De Clercq E
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):119-34. PubMed ID: 1371690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current acquisitions in antiviral drugs (anti-HIV)].
    De Clercq E; Snoeck R
    J Pharm Belg; 1992; 47(4):317-22. PubMed ID: 1383488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclic nucleosides as antiviral compounds.
    Freeman S; Gardiner JM
    Mol Biotechnol; 1996 Apr; 5(2):125-37. PubMed ID: 8734425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.